M. Goudier

发表

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma.

F. Sturtz, D. Belpomme, E. Pujade-Lauraine, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial

M. Namer, J. Bonneterre, A. Monnier, 2007, British Journal of Cancer.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

M. Namer, J. Bonneterre, A. Monnier, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Squamous cell carcinoma of the esophagus. Treatment by combined vincristine‐methotrexate plus folinic acid rescue and cisplatin before radiotherapy

J. Douillard, M. Resbeut, M. Goudier, 1985, Cancer.

10-year follow-up update of French adjuvant study group 05 trial: FEC 100 regimen remains superior to FEC 50 in adjuvant chemotherapy of poor prognosis, node-positive, early breast cancer patients

M. Namer, J. Bonneterre, P. Fumoleau, 2003 .

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

J. Robert, E. Gamelin, M. Boisdron-Celle, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial.

J. Bonneterre, A. Monnier, P. Fumoleau, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial.

S. Schraub, M. Namer, A. Monnier, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program

L. Zelek, M. Namer, J. Pierga, 2004, Breast Cancer Research and Treatment.

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.

M. Namer, J. Bonneterre, M. Campone, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Does time interval between surgery and adjuvant chemotherapy initiation modify treatment efficacy in operable, breast cancer patients? French Adjuvant Study Group (FASG) results

M. Namer, J. Bonneterre, A. Monnier, 2005 .

[Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group].

B. Coiffier, B. Roullet, T. Facchini, 1991, Bulletin du cancer.